This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
US drug firms provide OAP discounts
Suicides fall after drug withdrawal
Fruit supplements “slow blindness”
Study into “safer” Alzheimer’s drug
Test to find chemotherapy match
Rivaroxaban “combats heart attacks”
New treatments should be introduced gradually to avoid later problems
Shareholders to meet over Merck deal
Drug “may halt” rheumatoid arthritis
Glaxo to license Dr Reddys drugs
ICON announces collaboration
Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration
« Previous
1
…
130
131
132
133
134
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: